Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy,and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants with Heterozygous Familial Hypercholesterolemia'. The following are the other relevant details related to the trial:
Therapeutic Area: Endocrinology & Metabolism
Trial Centre(s):
National University Hospital
Trial Status: NA
Principal Investigator(s):
Dr Chen Ching Kit
Published by HT Digital Content Services with permission from Health Daily Digest....